Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 40 contracts
Sources: Registration Rights Agreement (Lightwave Logic, Inc.), Registration Rights Agreement (Workhorse Group Inc.), Registration Rights Agreement (Cognition Therapeutics Inc)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 28 contracts
Sources: Registration Rights Agreement (Crescent Biopharma, Inc.), Registration Rights Agreement (Brazil Potash Corp.), Registration Rights Agreement (Summit Therapeutics Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 13 contracts
Sources: Registration Rights Agreement (Kalaris Therapeutics, Inc.), Registration Rights Agreement (Verrica Pharmaceuticals Inc.), Registration Rights Agreement (Adagio Medical Holdings, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 9 contracts
Sources: Registration Rights Agreement (GRAIL, Inc.), Registration Rights Agreement (Oruka Therapeutics, Inc.), Registration Rights Agreement (Shattuck Labs, Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time Investors when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 9 contracts
Sources: Registration Rights Agreement (Pineapple Financial Inc.), Registration Rights Agreement (Portage Biotech Inc.), Registration Rights Agreement (MEI Pharma, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding the Investor.
Appears in 7 contracts
Sources: Registration Rights Agreement (VYNE Therapeutics Inc.), Registration Rights Agreement (Galecto, Inc.), Registration Rights Agreement (Glycomimetics Inc)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 7 contracts
Sources: Registration Rights Agreement (Enveric Biosciences, Inc.), Registration Rights Agreement (Enveric Biosciences, Inc.), Registration Rights Agreement (Advent Technologies Holdings, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information, in each case applicable to the Registrable Securities.
Appears in 6 contracts
Sources: Registration Rights Agreement (X4 Pharmaceuticals, Inc), Registration Rights Agreement (Humacyte, Inc.), Registration Rights Agreement (Meta Materials Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 4 contracts
Sources: Registration Rights Agreement (Athira Pharma, Inc.), Registration Rights Agreement (Athira Pharma, Inc.), Registration Rights Agreement (Zenas BioPharma, Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf applicable Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the applicable Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 3 contracts
Sources: Registration Rights Agreement (In8bio, Inc.), Registration Rights Agreement (Equillium, Inc.), Registration Rights Agreement (Equillium, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Shelf Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (electroCore, Inc.), Registration Rights Agreement (Transenterix, Inc.)
Notifications. The Company will notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Replimune Group, Inc.), Registration Rights Agreement (Pyxis Oncology, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional informationinformation regarding the Investors.
Appears in 2 contracts
Sources: Registration Rights Agreement (Jade Biosciences, Inc.), Registration Rights Agreement (Jade Biosciences, Inc.)
Notifications. The Company will promptly notify the Investor promptly Purchaser of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Athira Pharma, Inc.), Registration Rights Agreement (Athira Pharma, Inc.)
Notifications. The Company will notify the Investor Buyer promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Alterola Biotech Inc.), Registration Rights Agreement (Bloomios, Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time Investors when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Vor Biopharma Inc.), Registration Rights Agreement (Belite Bio, Inc)
Notifications. The Company will promptly notify the Investor promptly Warrantholder of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor Buyer promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will notify the Investor Sellers promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Zevra Therapeutics, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Alto Neuroscience, Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf initial Registration Statement or any New new Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New new Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement, Warrant Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement, Warrant Initial Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Inhibikase Therapeutics, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any Registration Statement and any subsequent amendment to the Shelf Registration Statement or any New Registration Statementthereto, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Brickell Biotech, Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement, any New Registration Statement or any New Special Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement, any Special Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed filed, and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information., in each case applicable to the Registrable Securities.
Appears in 1 contract
Sources: Registration Rights Agreement (Aspira Women's Health Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Outset Medical, Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time Holders when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (ChargePoint Holdings, Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any Second Registration Statement, as applicable, or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement or any Second Registration Statement, as applicable, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Camp4 Therapeutics Corp)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.. (b)
Appears in 1 contract
Sources: Registration Rights Agreement (AEON Biopharma, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information, in each case applicable to the Registrable Securities.
Appears in 1 contract